All Stories

  1. From pandemic Covid-19 to endemic Sars-2 Omicron Disease: is Long Covid still an issue?
  2. Commentary to “Mogamulizumab-induced photosensitivity in patients with mycosis fungoides and other T-cell neoplasms” by Y. Masuda et al .
  3. S1-Guidelines on UV phototherapy and photochemotherapy
  4. S1-Leitlinie zur UV-Phototherapie und Photochemotherapie
  5. Phototherapy, psoriasis, and the age of biologics
  6. Synergism between narrowband ultraviolet B phototherapy and etanercept for the treatment of plaque-type psoriasis
  7. Long-term (6 and 12 months) follow-up of two prospective, randomized, controlled phase III trials of photodynamic therapy with BF-200 ALA and methyl aminolaevulinate for the treatment of actinic keratosis
  8. History of phototherapy in dermatology
  9. Photodynamic therapy with BF-200 ALA for the treatment of actinic keratosis: results of a multicentre, randomized, observer-blind phase III study in comparison with a registered methyl-5-aminolaevulinate cream and placebo
  10. Comparison of psoralen plus ultraviolet A therapy and biologics in moderate to severe chronic plaque psoriasis
  11. 5-Methoxypsoralen plus ultraviolet (UV) A is superior to medium-dose UVA1 in the treatment of severe atopic dermatitis: a randomized crossover trial
  12. Effect of Work-Related Ultraviolet Exposure and Ophthalmic Changes in Austrian Farmers: The SVB-UV Study
  13. Photodermatology
  14. A tribute to Giulio Jori on his 70th birthday
  15. European S3-Guidelines on the systemic treatment of psoriasis vulgaris
  16. Medium-dose is more effective than low-dose ultraviolet A1 phototherapy for localized scleroderma as shown by 20-MHz ultrasound assessment
  17. Oral vs. bath PUVA using 8-methoxypsoralen for chronic palmoplantar eczema
  18. Failure of short-term psoralen and ultraviolet A light maintenance treatment to prevent early relapse in patients with chronic recurring plaque-type psoriasis
  19. Dermatological Phototherapy and Photodiagnostic Methods
  20. Polymorphous light eruption
  21. Antinuclear antibodies in patients with polymorphic light eruption: a long-term follow-up study
  22. Recommendation: Daily sun protection in the prevention of chronic UV-induced skin damage
  23. A prospective, randomized, double-blind, placebo-controlled study on the influence of a hormone replacement therapy on skin aging in postmenopausal women
  24. Photodegradation of folic acid during extracorporeal photopheresis
  25. Randomized, double-blind comparison of 1 mg/L versus 5 mg/L methoxsalen bath-PUVA therapy for chronic plaque-type psoriasis
  26. Efficacy of 3 different light doses in the treatment of actinic keratosis with 5-aminolevulinic acid photodynamic therapy: A randomized, observer-blinded, intrapatient, comparison study
  27. Corrigendum and Errata
  28. Review of the potential photo-cocarcinogenicity of topical calcineurin inhibitors. Position statement of the European Dermatology Forum
  29. Effects and side-effects of 2% progesterone cream on the skin of peri- and postmenopausal women: results from a double-blind, vehicle-controlled, randomized study
  30. The course of anticoagulation after extracorporeal photochemotherapy
  31. UVA-induced oxidative damage and cytotoxicity depend on the mode of exposure
  32. Photodynamische Therapie bei aktinischen Keratosen und Morbus Bowen
  33. Ultraviolet protective performance of photoprotective lipsticks: change of spectral transmittance because of ultraviolet exposure
  34. Topical aminolaevulinic acid-based photodynamic therapy as a treatment option for psoriasis? Results of a randomized, observer-blinded study
  35. Caterpillar Dermatitis in Two Siblings due to the Larvae of Thaumetopoea processionea L., the Oak Processionary Caterpillar
  36. The oak processionary caterpillar as the cause of an epidemic airborne disease: survey and analysis
  37. Observer-blind, randomized, intrapatient comparison of a novel 1% coal tar preparation (Exorex) and calcipotriol cream in the treatment of plaque type psoriasis
  38. Assessment of thickness of photoprotective lipsticks and frequency of reapplication: results from a laboratory test and a field experiment
  39. Comparison of epidermal hydration and skin surface lipids in healthy individuals and in patients with atopic dermatitis
  40. Mechanisms of phototherapy and photochemotherapy for photodermatoses
  41. Clinical Evidence of the Endocrinological Influence of a Triphasic Oral Contraceptive Containing Norgestimate and Ethinyl Estradiol in Treating Women with Acne vulgaris
  42. Einfluss einer Hormonersatz-Therapie auf die Hautalterung
  43. A comparison of psoralen plus ultraviolet A (PUVA) monotherapy, tacalcitol plus PUVA and tazarotene plus PUVA in patients with chronic plaque-type psoriasis
  44. Wirksamkeit und Sicherheit von Tacalcitol-Salbe in der Langzeitanwendung bei chronischer Plaque Psoriasis. Long-term efficacy and safety of tacalcitol ointment in patients with chronic plaque psoriasis
  45. Objective assessment of photoageing effects using high-frequency ultrasound in PUVA-treated psoriasis patients
  46. Subcorneal colocalization of the small heat shock protein, hsp27, with keratins and proteins of the cornified cell envelope
  47. Erythema and pigmentation
  48. Dengue hemorrhagic fever in a British travel guide
  49. Hereditary, focal, transgressive palmoplantar keratoderma with associated clinical findings: a new entity?
  50. Long-term efficacy and safety of tacalcitol ointment in patients with chronic plaque psoriasis
  51. Assessment of acitretin-treated female patients of childbearing age and subsequent risk of teratogenicity
  52. Messung der Hautdicke mittels Hochfrequenzultraschall zur Objektivierung einer Hormonersatztherapie in der Perimenopause
  53. High-dose versus medium-dose UVA1 phototherapy for patients with severe generalized atopic dermatitis
  54. Change of Ultraviolet Absorbance of Sunscreens by Exposure to Solar-Simulated Radiation
  55. The influence of hormone replacement therapy on skin ageing
  56. Phototherapy for psoriasis
  57. Oral dexamethasone pulse treatment for vitiligo
  58. Correlation between 8-methoxypsoralen bath-water concentration and photosensitivity in bath-PUVA treatment
  59. American Academy of Dermatology Consensus Conference on UVA protection of sunscreens: Summary and recommendations
  60. Narrow‐band ultraviolet B (TL‐01) phototherapy is an effective and safe treatment option for patients with severe seborrhoeic dermatitis
  61. Correlation between bathing time and photosensitivity in 8-methoxypsoralen (8-MOP) bath PUVA
  62. Topical Treatment with Liposomes Containing T4 Endonuclease V Protects Human Skin In Vivo from Ultraviolet-Induced Upregulation of Interleukin-10 and Tumor Necrosis Factor-α
  63. Half-side comparison study on the efficacy of 8-methoxypsoralen bath-PUVA versus narrow-band ultraviolet B phototherapy in patients with severe chronic atopic dermatitis
  64. Efficacy of topical photodynamic therapy of a giant keratoacanthoma demonstrated by partial irradiation
  65. Low-Dose 2-Chlorodeoxyadenosine for the Treatment of Mycosis Fungoides
  66. Half-side comparison of erythemogenic versus suberythemogenic UVA doses in oral photochemotherapy of psoriasis
  67. Narrowband UV-B Phototherapy vs Photochemotherapy in the Treatment of Chronic Plaque-Type Psoriasis
  68. Increased dermal angiogenesis after low-intensity laser therapy for a chronic radiation ulcer determined by a video measuring system
  69. Ultrastructural Changes in PAM Cells After Photodynamic Treatment with Delta-Aminolevulinic Acid-Induced Porphyrins or Photosan
  70. Generalized Pustular Psoriasis of Pregnancy (Impetigo herpetiformis)
  71. Porphyria Cutanea Tarda Induced by the Use of Pravastatin
  72. Flow cytometric quantification of UY-induced cell death in a human squamous cell carcinoma-derived cell line: dose and kinetic studies
  73. Consensus Workshop on the Toxic Effects of Long-term PUVA Therapy
  74. Linear focal elastosis (elastotic striae): increased number of elastic fibres determined by a video measuring system
  75. Wells' syndrome responsive to PUVA therapy
  76. Handbuch der dermatologischen Phototherapie und Photodiagnostik
  77. Concentration of etretinate in plasma and subcutaneous fat after long-term acitretin
  78. Increased Expression of the 72-kDa Heat Shock Protein and Reduced Sunburn Cell Formation in Human Skin After Local Hyperthermia
  79. Stress proteins in the cellular response to ultraviolet radiation
  80. Bullous Pemphigoid Induced by PUVA Therapy
  81. Skin Tumors in Photochemotherapy for Psoriasis: A Single-Center Follow-Up of 496 Patients
  82. Photodynamic therapy of epithelial skin tumours using delta-aminolaevulinic acid and desferrioxamine
  83. Renal allograft rejection controlled by photopheresis
  84. Immunohistochemistry of Port-wine Stains and Normal Skin With Endothelium-Specific Antibodies PAL-E, Anti—ICAM-1, Anti—ELAM-1, and Anti—Factor VIIIrAg
  85. Safety and Effectiveness of an Aggressive and Individualized Bath-PUVA Regimen in the Treatment of Psoriasis
  86. Comparison of narrow-band (311 nm) UVB and broad-band UVA after oral or bath-water 8-methoxypsoralen in the treatment of psoriasis
  87. UVA does not photoreactivate pyrimidine dimers in cultured human fibroblasts
  88. Lethal photosensitization by endogenous porphyrins of PAM cells — modification by desferrioxamine
  89. Results and tissue healing after copper-vapour laser (at 578 nm) treatment of port wine stains and facial telangiectasias
  90. 8-MOP vs 5-MOP
  91. A reappraisal of the use of 5-methoxypsoralen in the therapy of psoriasis
  92. Severe sun sensitivity and the presence of antinuclear antibodies in patients with polymorphous light eruption-like lesions
  93. Photochemotherapy for severe psoriasis without or in combination with acitretin: A randomized, double-blind comparison study
  94. Letter from the president of ESP
  95. Photopatch testing: The 5-year experience of the German, Austrian, and Swiss Photopatch Test Group
  96. Relative efficacy of 335 and 365 nm radiation in photochemotherapy of psoriasis
  97. Genital carcinomas in psoriasis patients treated with photochemotherapy
  98. Cyclosporin A in combination with photochemotherapy (PUVA) in the treatment of psoriasis
  99. Photochemotherapy improves chronic cutaneous graft-versus-host disease
  100. Treatment of psoriatic arthritis by extracorporeal photochemotherapy
  101. UVA and human skin
  102. From the president of ESP
  103. Reply
  104. Photosensitivity and Hyperpigmentation in Amiodarone-Treated Patients: Incidence, Time Course, and Recovery
  105. An Unusual Combination of Phototoxicity and Stevens-Johnson Syndrome due to Antimalarial Therapy
  106. Results of therapy for psoriasis using retinoid and photochemotherapy (RePUVA)
  107. Permanent cure of hydroa vacciniforme after chemotherapy for Hodgkin's disease
  108. Effect of nicotinamide on the phototest reaction in polymorphous light eruption
  109. Phototherapeutic, Photobiologic, and Photosensitizing Properties of Khellin
  110. Treatment of vitiligo with khellin and ultraviolet A
  111. 5-Methoxypsoralen (Bergapten) for photochemotherapy
  112. Do Oral Carotenoids Protect Human Skin Against Ultraviolet Erythema, Psoralen Phototoxicity, and Ultraviolet-Induced DNA Damage?
  113. UV-Induced unscheduled DNA synthesis in human skin: Dose response, correlation with erythema, time course and split dose exposure in vivo
  114. Skin tumors in the European PUVA Study
  115. Immediate Pigment Darkening Phenomenon. A Reevaluation of Its Mechanisms
  116. Nonmelanoma skin tumors in long-term photochemotherapy treatment of psoriasis
  117. Polymorphous light eruption: Action spectrum and photoprotection
  118. PUVA TREATMENT STRATEGIES AND CANCER RISK
  119. Dysplastic nevus syndrome with multiple primary amelanotic melanomas in oculocutaneous albinism
  120. Retinoids and PUVA in psoriasis
  121. Photochemotherapy for cutaneous T cell lymphoma
  122. ISOTRETINOIN-PUVA FOR PSORIASIS
  123. Serum Levels of 8-Methoxypsoralen in Two Different Drug Preparations: Correlation with Photosensitivity and UV-A Dose Requirements for Photochemotherapy
  124. Effects of whole body UV-irradiation on oxygen delivery from the erythrocyte
  125. Selective accumulation of lipid within melanocytes during photochemotherapy (PUVA) of psoriasis
  126. The syndrome of milker's nodules in burn injury
  127. Unscheduled DNA synthesis in normal human skin after single and combined doses of V-A, UV-B and UV-A with methoxsalen (PUVA)
  128. ORAL 8-METHOXYPSORALEN PHOTOCHEMOTHERAPY OF PSORIASIS
  129. Ultraviolet Light Depletes Surface Markers of Langerhans Cells
  130. Clinical aspects of photochemotherapy
  131. Diffuse melanosis in metastatic melanoma
  132. Keratoses and nonmelanoma skin tumors in long-term photochemotherapy (PUVA)
  133. Long-term photochemotherapy: histopathological and immunofluorescence observations in 243 patients
  134. Immunofluorescence Demonstration of Type IV Collagen and a Noncollagenous Glycoprotein in Thickened Vascular Basal Membranes in Protoporphyria
  135. 5-Methoxypsoralen (Bergapten) in photochemotherapy of psoriasis
  136. PUVA Suppresses the Proliferative Stimulus Produced by Stripping on Hairless Mice
  137. Epidermolytic hereditary palmoplantar keratoderma.
  138. Photochemotherapie bei Psoriasis: Steigerung der Wirksamkeit durch ein orales aromatisches Retinoid
  139. Induction of UV light tolerance by PUVA in patients with polymorphous light eruption
  140. PUVA-treatment of urticaria pigmentosa
  141. Augmentation of Oral Methoxsalen-Photochemotherapy with an Oral Retinoic Acid Derivative
  142. Photochemotherapy for pustular psoriasis (von Zumbusch)
  143. Phototesting and dosimetry for photochemotherapy
  144. Ultrastructural Localization Of Immunoglobulins In Skin Of Patients With Dermatitis Herpetiformis
  145. Photochemotherapy for Psoriasis With Orally Administered Methoxsalen
  146. Herpes Gestationis: Fine Structural Pattern Of Immunoglobulin Deposits In The Skin In Vivo
  147. Mouse Model For Protoporphyria. III. Experimental Production of Chronic Erythropoietic Protoporphyria-like Skin Lesions
  148. Protective action of beta-carotene against lethal photosensitization of fibroblasts in vitro*
  149. Mouse Model For Protoporphyria I. The Liver and Hepatic Protoporphyrin Crystals
  150. Mouse Model For Protoporphyria II. Cellular and Subcellular Events in the Photosensitivity Flare of the Skin
  151. Glycocalyx of Epidermal Cells in Vitro: Demonstration and Enzymatic Removal
  152. Immunochemical localization ofin Vivo bound immunoglobulins in pemphigus vulgaris epidermis
  153. The giant melanosome: A model of deranged melanosome-morphogenesis
  154. Bleivergiftung: Feinstrukturelle Lokalisation von Blei im Gingivagewebe
  155. Cicatricial Pemphigoid
  156. Continuity of intercellular space and endoplasmic reticulum of keratinocytes
  157. Langerhans cells in cell culture
  158. Elektronenmikroskopischer Nachweis einer mitotischen Langerhans-Zelle in normaler menschlicher Epidermis
  159. Are Melanosome Complexes Lysosomes?
  160. Bindegewebsmelanocyten beim Menschen. Elektronenmikroskopische und histochemische Untersuchungen beim Mongolenfleck und blauem Naevus
  161. Immunofluorescenzuntersuchungen (IF) an Haut und D�nndarmschleimhaut bull�ser Dermatosen
  162. Ultrastrukturelle Lokalisation von Silber bei Argyrose
  163. Permeability of the epidermis and the phagocytic activity of keratinocytes